A Randomized, Double-Blind, Placebo-Controlled Study of 4-hydroxytamoxifen Topical Gel in Women With Mammographically Dense Breast
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2017
At a glance
- Drugs Afimoxifene (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 21 Nov 2017 Status changed from not yet recruiting to recruiting.
- 10 May 2017 Planned initiation date changed from 30 Apr 2017 to 30 May 2017.
- 11 Apr 2017 Planned initiation date changed from 1 May 2017 to 15 Apr 2017.